Description of the blood test:

The combined test for Dengue Antibodies (IgM/IgG) and the Early Antigen (NS1) is a comprehensive diagnostic tool used to detect infection with the Dengue virus. This virus is transmitted to humans through the bites of infected Aedes mosquitoes. By combining the detection of the NS1 antigen (which appears in the very early stages of the disease) with the search for specific antibodies (which develop as the immune system responds), this test provides a wide “diagnostic window.” This allows for the identification of the virus from the first day of fever throughout the recovery phase, ensuring that the infection is not missed regardless of when the patient seeks medical attention.

What does the analysis represent?

• NS1 Antigen (Early Ag): A viral protein that circulates in the blood during the acute phase of infection. It is a highly specific marker for the virus itself.
• IgM Antibodies: Produced by the immune system shortly after the NS1 antigen appears; they indicate a current or very recent primary infection.
• IgG Antibodies: Appear later and signify a past infection or a secondary (repeat) infection, which can be more severe.

Performance: Rapid immunochromatographic assay or ELISA of a venous blood sample.

Recommendations for the test (General)

• Time: Blood collection is best performed during the morning hours.
• Fasting: A food intake pause of at least 4 hours is recommended.
• Timing of the test: Ideally performed as soon as symptoms (like high fever) appear. The NS1 component is most effective within the first 1–5 days of illness.
• Important: If you have recently traveled to tropical or subtropical regions and develop a fever, this test is a clinical priority.

What can affect the results?

• Test Timing: Taking the test too late (after 7–10 days) may result in a negative NS1, even if the infection was present.
• Cross-reactivity: Patients previously vaccinated for or infected with related flaviviruses (such as Zika or Yellow Fever) may show cross-reactive IgG results.
• Immune Status: The speed and strength of the antibody response can vary depending on whether it is the patient’s first or second time contracting Dengue.

When to take the test?

• Recommendations: Prescribed for individuals experiencing “breakbone fever” symptoms: sudden high fever, severe headache (especially behind the eyes), joint and muscle pain, rash, or minor bleeding from the nose or gums.
• Preparation: Standard clinical preparation for blood work; avoid heavy exercise 24 hours prior.

How to interpret the results?

The interpretation of data is the exclusive responsibility of an infectious disease specialist. A positive NS1 result is a definitive marker of an active Dengue infection. The presence of IgM and IgG antibodies helps the physician determine if the infection is primary or a more dangerous secondary reactivation. Only an expert can correlate these laboratory findings with the patient’s platelet count and clinical state to prevent complications like Dengue Hemorrhagic Fever.

Possible further investigations

• Complete Blood Count (CBC): To monitor platelet levels and hematocrit, which are critical for assessing the severity of the disease.
• Liver Function Tests (ALT, AST): To evaluate potential liver involvement caused by the virus.
• PCR for Dengue Virus: For the most definitive identification of the specific viral serotype.
• Consultation with an Infectious Disease Specialist: To establish a monitoring and hydration plan.

When does the next step make sense?

Since Dengue can progress rapidly, a positive result for any of the markers (Ag or Ab) requires immediate medical follow-up. The next step is a consultation with a specialist to manage symptoms and monitor for warning signs of severe disease, ensuring a safe recovery.

👉 If necessary, you can discuss the test results with our specialized — dermatologist disease specialist (Doctors – TAMC).